SIS
DFTX

Sound Income Strategies’s Definium Therapeutics DFTX Stock Holding History

Sound Income Strategies’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,690
Closed -$76K – 1645
2026
Q1 		$76K Hold
3,690
– – ﹤0.01% 690
2025
Q4 		$55.5K Buy
3,690
+9
+0.2% +$111 ﹤0.01% 753
2025
Q3 		$46K Buy
+3,681
New +$34.3K ﹤0.01% 576

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sound Income Strategies's DFTX Position: Q2 2026 in Review

Sound Income Strategies sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 3,690 shares — an estimated $76K sold.

Sound Income Strategies first reported a position in DFTX in Q3 2025 and held it in 3 quarters. The position peaked at $76K in Q1 2026. 219 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Sound Income Strategies reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 3,690 Definium Therapeutics shares in Q2 2026, an estimated $76K.
  • Sound Income Strategies first reported a position in Definium Therapeutics in Q3 2025 and held it in 3 quarters.
  • Sound Income Strategies's Definium Therapeutics position peaked at $76K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.